A Trial of Incentives and Peer Mentors to Improve Diabetic Outcomes
NCT ID: NCT01125969
Last Updated: 2018-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
240 participants
INTERVENTIONAL
2011-03-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The intervention is based on epidemiologic evidence, randomized controlled trials, and pilot studies demonstrating: 1) Lottery based financial incentives are a powerful motivator of behavior change; 2) One-on-one peer mentoring is a flexible, cost-efficient means of increasing DM specific social support and may be particularly salient in minority communities; and 3) Matching patients with poorly controlled DM with a similar individual from their community who has gained control of their DM draws on existing community assets in creating an inherently culturally competent intervention. DM patients with poor DM control will be randomized to 1 of 4 arms: usual care; telephone based one-on-one peer mentoring; lottery based financial incentives; and peer mentoring plus financial incentives.
The Specific Aims are to test: 1) The effectiveness of telephone based one-on-one peer mentoring in improving glycemic control relative to usual care; 2) The effectiveness of lottery based financial incentives in improving glycemic control relative to usual care; 3) The effectiveness of combining peer mentoring and financial incentives relative to control; and 4) The relative cost effectiveness of all four approaches. In exploratory analyses, we will examine whether African American patients enrolled in intervention arms have greater improvement in glycemic control than white patients, whether intervention group patients experience greater improvements in blood pressure (BP) and lipid control, and whether peer mentors experience improvements in their own health. We will pair mentors with mentees based on race, gender, age, and disease severity. The active intervention will be run for a 6-month time period, with participants followed for an additional 6 months to determine if effects persist post intervention.
The proposed interventions address multiple barriers to effective disease management common among patients with DM. If effective, these interventions could provide important models for improving glycemic control in general and, in particular, for addressing racial disparities in DM outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Diabetes Control Through Peer Counseling and Incentives
NCT01125956
Social Incentives to Improve Diabetes
NCT02961192
Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes
NCT06459596
Peer-Led Self-Management Support in "Real World" Clinical and Community Settings
NCT01517919
Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.
NCT02012478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Education
Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia
Incentive
Incentives
Incentives will be offered for checking blood glucose each morning and for control of blood glucose (between 80-140 mg/dL).
Education
Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia
Peer Mentoring
Education
Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia
Peer mentoring
Participant is assigned a peer mentor who is matched on gender, race and age and who achieved good glucose control after previously having poor glucose control.
Incentives and Peer Mentoring
Incentives
Incentives will be offered for checking blood glucose each morning and for control of blood glucose (between 80-140 mg/dL).
Education
Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia
Peer mentoring
Participant is assigned a peer mentor who is matched on gender, race and age and who achieved good glucose control after previously having poor glucose control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incentives
Incentives will be offered for checking blood glucose each morning and for control of blood glucose (between 80-140 mg/dL).
Education
Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia
Peer mentoring
Participant is assigned a peer mentor who is matched on gender, race and age and who achieved good glucose control after previously having poor glucose control.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 30 to 70 years old
* persistently poor glucose control, defined as having the last two HbA1c values \> 8%, with at least one measure within 3 months of enrollment
* receiving treatment for diabetes mellitus at one of five University of Pennsylvania outpatient clinics
Exclusion Criteria
* unable to provide informed consent
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith A. Long, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10022605
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.